Literature DB >> 19009653

Chronic hepatitis C is a common associated with hepatic granulomas.

Ned Snyder1, Juan G Martinez, Shu-Yuan Xiao.   

Abstract

AIM: To determine the most frequent etiologies of hepatic epithelioid granulomas, and whether there was an association with chronic hepatitis C virus (HCV).
METHODS: Both a retrospective review of the pathology database of liver biopsies at our institution from 1996 through 2006 as well as data from a prospective study of hepatic fibrosis markers and liver biopsies from 2003 to 2006 were reviewed to identify cases of hepatic epithelioid granulomas. Appropriate charts, liver biopsy slides, and laboratory data were reviewed to determine all possible associations. The diagnosis of HCV was based on a positive HCV RNA.
RESULTS: There were 4578 liver biopsies and 36 (0.79%) had at least one epithelioid granuloma. HCV was the most common association. Fourteen patients had HCV, and in nine, there were no concurrent conditions known to be associated with hepatic granulomas. Prior interferon therapy and crystalloid substances from illicit intravenous injections did not account for the finding. There were hepatic epithelioid granulomas in 3 of 241 patients (1.24%) with known chronic HCV enrolled in the prospective study of hepatic fibrosis markers.
CONCLUSION: Although uncommon, hepatic granulomas may be part of the histological spectrum of chronic HCV. When epithelioid granulomas are found on the liver biopsy of someone with HCV, other clinically appropriate studies should be done, but if nothing else is found, the clinician can be comfortable with an HCV association.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19009653      PMCID: PMC2766119          DOI: 10.3748/wjg.14.6366

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

Review 1.  Hepatic granulomas in chronic hepatitis C.

Authors:  A Mert; F Tabak; R Ozaras; V Tahan; H Senturk; G Ozbay
Journal:  J Clin Gastroenterol       Date:  2001-10       Impact factor: 3.062

Review 2.  National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

Authors: 
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

3.  APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C.

Authors:  Ned Snyder; Leka Gajula; Shu-Yuan Xiao; James Grady; Bruce Luxon; Daryl T-Y Lau; Roger Soloway; John Petersen
Journal:  J Clin Gastroenterol       Date:  2006-07       Impact factor: 3.062

4.  Pulmonary sarcoidosis induced by interferon-alpha therapy.

Authors:  Kelly J Butnor
Journal:  Am J Surg Pathol       Date:  2005-07       Impact factor: 6.394

5.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

6.  Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases.

Authors:  Norman Gitlin
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-08       Impact factor: 2.566

7.  The development of hepatic granulomas following interferon-alpha2b therapy for chronic hepatitis C infection.

Authors:  B M Ryan; G S McDonald; R Pilkington; D Kelleher
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-04       Impact factor: 2.566

8.  Hepatic granulomas: a 10 year single centre experience.

Authors:  D R Gaya; D Thorburn; K A Oien; A J Morris; A J Stanley
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

Review 9.  [Sarcoidosis following combined ribavirin and interferon therapy: a case report and review of the literature].

Authors:  I Alfageme Michavila; M Merino Sánchez; J Pérez Ronchel; I Lara Lara; E Suárez García; J López Garrido
Journal:  Arch Bronconeumol       Date:  2004-01       Impact factor: 4.872

10.  The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.

Authors:  Ned Snyder; Audrey Nguyen; Leka Gajula; Roger Soloway; Shu-Yuan Xiao; Daryl T-Y Lau; John Petersen
Journal:  Clin Chim Acta       Date:  2007-03-19       Impact factor: 3.786

View more
  3 in total

Review 1.  [Hepatic granuloma-A diagnostic challenge].

Authors:  Ludwig J Horst; Sören Weidemann; Ansgar W Lohse; Marcial Sebode
Journal:  Z Rheumatol       Date:  2022-06-28       Impact factor: 1.530

2.  Sarcoidosis and chronic hepatitis C: a case report.

Authors:  Vadim Brjalin; Riina Salupere; Valentina Tefanova; Kaiu Prikk; Natalia Lapidus; Enn Jõeste
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

3.  Delayed enhanced hepatosplenic sarcoid nodules on computed tomography in an interferon-naïve hepatitis C patient: a case report and review of the literature.

Authors:  Takuhiro Ugajin; Hiroyuki Miyatani; Katsuhiko Matsuura; Shinya Ushimaru; Kiyoka Omoto; Mitsuhiro Nokubi; Tomohisa Ohkohchi; Yukio Yoshida
Journal:  Clin J Gastroenterol       Date:  2012-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.